Verrica Pharmaceuticals's total assets for Q3 2024 were $32.93M, a decrease of -36.69% from the previous quarter. DE:1NE total liabilities were $66.98M for the fiscal quarter, a 2.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.